- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/085 - Staphylococcus
Patent holdings for IPC class A61K 39/085
Total number of patents in this class: 591
10-year publication summary
|
48
|
36
|
44
|
45
|
38
|
30
|
23
|
28
|
31
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1630 |
58 |
| The University of Chicago | 1452 |
35 |
| New York University | 1779 |
18 |
| Evaxion Biotech A/S | 55 |
14 |
| Socpra Sciences et Genie S.E.C. | 205 |
13 |
| The Regents of the University of California | 20296 |
12 |
| Merck Sharp & Dohme Corp. | 2189 |
12 |
| Wyeth LLC | 649 |
11 |
| Abvacc, Inc. | 13 |
11 |
| Janssen Pharmaceuticals, Inc. | 442 |
10 |
| Novartis AG | 10534 |
9 |
| NeoTX Therapeutics Ltd. | 14 |
9 |
| MedImmune, LLC | 500 |
8 |
| Vaxxinova US, Inc. | 50 |
8 |
| Children's Medical Center Corporation | 1908 |
7 |
| The Texas a & M University System | 1787 |
7 |
| The Brigham and Women's Hospital, Inc. | 2230 |
6 |
| Xbiotech, Inc. | 63 |
6 |
| The Regents of the University of Michigan | 4801 |
5 |
| Boise State University | 121 |
5 |
| Other owners | 327 |